SIBN 📈 Si-Bone - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8257041090

SIBN: Surgical Implants, Bone Products, Medical Devices

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Web URL: https://si-bone.com

Additional Sources for SIBN Stock

SIBN Stock Overview

Market Cap in USD 569m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Supplies
IPO / Inception 2018-10-17

SIBN Stock Ratings

Growth 5y -47.5%
Fundamental -37.5%
Dividend -
Rel. Strength Industry -1588
Analysts 4.56/5
Fair Price Momentum 10.86 USD
Fair Price DCF -

SIBN Dividends

No Dividends Paid

SIBN Growth Ratios

Growth Correlation 3m -4.9%
Growth Correlation 12m -71%
Growth Correlation 5y -41.4%
CAGR 5y -8.64%
CAGR/Mean DD 5y -0.23
Sharpe Ratio 12m -0.74
Alpha -72.99
Beta 1.47
Volatility 51.05%
Current Volume 519.2k
Average Volume 20d 291.5k
What is the price of SIBN stocks?
As of December 22, 2024, the stock is trading at USD 13.25 with a total of 519,180 shares traded.
Over the past week, the price has changed by -4.11%, over one month by +5.93%, over three months by -17.56% and over the past year by -34.68%.
Is Si-Bone a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Si-Bone (NASDAQ:SIBN) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.47 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIBN as of December 2024 is 10.86. This means that SIBN is currently overvalued and has a potential downside of -18.04%.
Is SIBN a buy, sell or hold?
Si-Bone has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy SIBN.
  • Strong Buy: 5
  • Buy: 4
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SIBN stock price target?
According to ValueRays Forecast Model, SIBN Si-Bone will be worth about 12.2 in December 2025. The stock is currently trading at 13.25. This means that the stock has a potential downside of -7.77%.
Issuer Forecast Upside
Wallstreet Target Price 23.2 75.2%
Analysts Target Price 28.4 114.2%
ValueRay Target Price 12.2 -7.8%